Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10713564

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10709742

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Original Discount Agreements 2024 13 Apremilast

Deadline: 31 Dec 2026

Germany

Ref. No.: 10707395

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10648609

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10648454

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Original Discount Contracts 2024 14 Bimatoprost Timolol Dosage Form Eye Drops As Single Dose Pipettes

Deadline: 31 Dec 2026

Germany

Ref. No.: 10647616

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10641939

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10628137

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Biologics Discount Agreements 2024 12 Dornase Alfa

Deadline: 31 Dec 2026

Germany

Ref. No.: 10624631

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Original Discount Agreements 2024 12 Tofacitinib

Deadline: 31 Dec 2026

Germany

Ref. No.: 10623190

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Discount Agreements 2024 13

Deadline: 31 Dec 2026

Germany

Ref. No.: 10607404

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Biologics Discount Agreements 2024 10 Pertuzumab Trastuzumab Drug Combination

Deadline: 31 Dec 2026

Germany

Ref. No.: 10579947

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Biologics Discount Agreements 2024 13 Somatropin

Deadline: 31 Dec 2026

Germany

Ref. No.: 10549827

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10531330

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Medicines Containing The Active Ingredient Rituximab In The Dosage Form Concentrate For Infusion Solution Atc L01Fa01

Deadline: 31 Oct 2026

Germany

Ref. No.: 10526727

EMD:Ref Document

Bid Value: Ref Document

209 Days Left

Discover Tenders by Uniforms Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Uniforms Sector

Filter Your Search

FREE Trial plan for all new users!